SCHEMBL18296234

SCHEMBL18296234

NC(=O)c1ccc(C2CC2)cn1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.60
KDM4E B2RXH2 1/20 0.60
GLA P06280 1/20 0.60
HTT P42858 1/20 0.60
SMN1; SMN2 Q16637 1/20 0.60
HIF1A Q16665 1/20 0.60
TDP1 Q9NUW8 1/20 0.60
L3MBTL1 Q9Y468 1/20 0.60
DGAT1 O75907 9/20 0.46
SOAT1 P35610 1/20 0.46
GSK3B P49841 1/20 0.43
PDE4A P27815 1/20 0.41
PDE4B Q07343 1/20 0.41
PDE4C Q08493 1/20 0.41
PDE4D Q08499 1/20 0.41
CYP2C9 P11712 1/20 0.41
SIRT6 Q8N6T7 1/20 0.40
HDAC4 P56524 1/20 0.38
PKMYT1 Q99640 1/20 0.38
ADORA3 P0DMS8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3736028 0.93 KMT2A (0.54) KMT2AKDM4EGLAHTTSMN1; SMN2
SCHEMBL22048083 0.89 KMT2A (0.53) KMT2AKDM4EGLAHTTSMN1; SMN2
SCHEMBL1585290 0.83 KDM4E (0.83) KMT2AKDM4EGLAHTTSMN1; SMN2
SCHEMBL24316507 0.81 KDM4E (0.60) KMT2AKDM4EGLAHTTSMN1; SMN2
Hydrochloric Acid SCHEMBL18036255 0.80 KDM4E (0.50) KMT2AKDM4EGLAHTTSMN1; SMN2
SCHEMBL13177598 0.79 KDM4E (0.57) KMT2AKDM4EGLAHTTSMN1; SMN2
SCHEMBL27174552 0.79 KDM4E (0.57) KMT2AKDM4EGLAHTTSMN1; SMN2
SCHEMBL14152280 0.77 MAPK1 (0.57) KMT2AKDM4EGLAHTTSMN1; SMN2
SCHEMBL25953857 0.77 MAPK1 (0.57) KMT2AKDM4EGLAHTTSMN1; SMN2
SCHEMBL14151857 0.76 KDM4E (0.97) KMT2AKDM4EGLAHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111601790-B Heteroaryl compounds as protein kinase inhibitors 福建海西新药创制股份有限公司 2023-03-31 CN claimed
WO-2026084434-A1 5-CYCLOPROPYLPICOLINAMIDE DERIVATIVE, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME FOR PREVENTNG OR TREATING CANCER 에이치케이이노엔 주식회사 2026-04-23 WO disclosed
WO-2026084434-A1 5-CYCLOPROPYLPICOLINAMIDE DERIVATIVE, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME FOR PREVENTNG OR TREATING CANCER 에이치케이이노엔 주식회사 2026-04-23 WO disclosed
CN-111601790-B Heteroaryl compounds as protein kinase inhibitors 福建海西新药创制股份有限公司 2023-03-31 CN disclosed
WO-2016196776-A2 INHIBITORS OF BRUTON'S TYROSINE KINASE PHARMACYCLICS LLC. (US) 2016-12-08 WO disclosed